Contact Us Site Map

PRAECIS Profile

PRAECIS PHARMACEUTICALS INCORPORATED
The Future in Drug Development

NASDAQ:PRCS

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.

PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for cancer indications, including non-Hodgkin's lymphoma and solid tumors, as well as an innovative drug discovery technology, Direct Select™ ,which enables the generation and practical use of ultra-large libraries for the discovery of orally active compounds for drug development.

The Company’s corporate headquarters and state-of-the-art research facility are located in Waltham, Massachusetts.